Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 25,602 shares at $17.84 ($458K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
Scheduled sale ($458k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.84 | 12,153 | $217K | 47.4% |
| 2 | $17.84 | 12,153 | $217K | 47.4% |
| 3 | $18.62 | 1,296 | $24K | 5.3% |
| Total | $17.88 avg | 25,602 | $458K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-02-28 | $2.4M | — | Filing → |